World Health Organization. Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/ncd-deaths-under-age-70-(percent-of-all-ncd-deaths). Accessed 2 January, 2024.
Norheim OF, Chang AY, Bolongaita S, Barraza-Lloréns M, Fawole A, Gebremedhin LT, et al. Halving premature death and improving quality of life at all ages: cross-country analyses of past trends and future directions. Lancet. 2024;404(10470):2437–46.
Google Scholar
Quiambao A, Malekpour MR, Golestani A, Heidari-Foroozan M, Ghamari SH, Abbasi-Kangevari M, et al. World health Organization’s guidance for tracking non-communicable diseases towards sustainable development goals 3.4: an initiative for facility-based monitoring. EClinicalMedicine. 2025;85:103304.
Google Scholar
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2133–61.
Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029–30.
Google Scholar
Ortega-Ortega M, Hanly P, Pearce A, Soerjomataram I, Sharp L. Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018. Int J Cancer. 2022;150(4):580–93.
Google Scholar
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.
Google Scholar
Frick C, Rumgay H, Vignat J, Ginsburg O, Nolte E, Bray F, et al. Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study. Lancet Glob Health. 2023;11(11):e1700–12.
Google Scholar
Murthy SS, Trapani D, Cao B, Bray F, Murthy S, Kingham TP, et al. Premature mortality trends in 183 countries by cancer type, sex, WHO region, and World Bank income level in 2000–19: a retrospective, cross-sectional, population-based study. Lancet Oncol. 2024;25(8):969–78.
Google Scholar
International Agency for Research on Cancer. Cancer Today. https://gco.iarc.who.int/today/en. Accessed 2 January, 2024.
United Nations. WHO mortality database. https://platform.who.int/mortality. Accessed 2 January, 2024.
United Nations. World population prospects, 2019. https://population.un.org/wpp/. Accessed 2 January, 2024.
United Nations. Human development index (HDI), 2020. https://hdr.undp.org/data-center/human-development-index#/indicies/HDI. Accessed 2 January, 2024.
Martinez R, Soliz P, Caixeta R, Ordunez P. Reflection on modern methods: years of life lost due to premature mortality-a versatile and comprehensive measure for monitoring non-communicable disease mortality. Int J Epidemiol. 2019;48(4):1367–76.
Google Scholar
Aburto JM, Wensink M, van Raalte A, Lindahl-Jacobsen R. Potential gains in life expectancy by reducing inequality of lifespans in Denmark: an international comparison and cause-of-death analysis. BMC Public Health. 2018;18(1):831.
Google Scholar
Kianmehr H, Zhang P, Luo J, Guo J, Pavkov ME, Bullard KM, et al. Potential gains in life expectancy associated with achieving treatment goals in US adults with type 2 diabetes. JAMA Netw Open. 2022;5(4):e227705.
Google Scholar
Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the human development index (2008–2030): a population-based study. Lancet Oncol. 2012;13(8):790–801.
Google Scholar
Marziano V, Bella A, Menegale F, Del Manso M, Petrone D, Palamara AT, et al. Estimating measles susceptibility and transmission patterns in Italy: an epidemiological assessment. Lancet Infect Dis. 2025;S1473–3099(25):00293–302.
Mortier P, Conde S, Alayo I, Amigo F, Ballester L, Cirici Amell R, et al. Premature death, suicide, and nonlethal intentional self-harm after psychiatric discharge. JAMA Netw Open. 2024;7(6):e2417131.
Google Scholar
Bundy JD, Mills KT, He H, LaVeist TA, Ferdinand KC, Chen J, et al. Social determinants of health and premature death among adults in the USA from 1999 to 2018: a national cohort study. Lancet Public Health. 2023;8(6):e422–31.
Google Scholar
Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052–90.
Google Scholar
Lai D, Hardy RJ. Potential gains in life expectancy or years of potential life lost: impact of competing risks of death. Int J Epidemiol. 1999;28(5):894–8.
Google Scholar
Bizuayehu HM, Ahmed KY, Kibret GD, Dadi AF, Belachew SA, Bagade T, et al. Global disparities of cancer and its projected burden in 2050. JAMA Netw Open. 2024;7(11):e2443198.
Google Scholar
Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11(2):e197-206.
Google Scholar
Modin L, Arshad A, Wilkes B, Benselin J, Lloyd C, Irving WL, et al. Epidemiology and natural history of hepatitis C virus infection among children and young people. J Hepatol. 2019;70(3):371–8.
Google Scholar
Li N, Deng Y, Zhou L, Tian T, Yang S, Wu Y, et al. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the global burden of disease study 2017. J Hematol Oncol. 2019;12(1):140.
Google Scholar
Sun K, Zhang B, Lei S, Zheng R, Liang X, Li L, et al. Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022. Chin Med J Engl. 2024;137(20):2429–36.
Google Scholar
Bidoli E, Virdone S, Hamdi-Cherif M, Toffolutti F, Taborelli M, Panato C, et al. Worldwide age at onset of female breast cancer: a 25-year population-based cancer registry study. Sci Rep. 2019;9(1):14111.
Google Scholar
Makhetha M, Chabilal N, Aldous C. Recent trends in hereditary breast cancer incidence by race and age in KwaZulu-Natal, South Africa: an 11-year single-centre retrospective study (2011–2021). Int J Cancer. 2024;154(1):65–70.
Google Scholar
Heer E, Harper A, Escandor N, Sung H, McCormack V, Fidler-Benaoudia MM. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health. 2020;8(8):e1027–37.
Google Scholar
Giaquinto AN, Sung H, Newman LA, Freedman RA, Smith RA, Star J, et al. Breast cancer statistics 2024. CA Cancer J Clin. 2024;74(6):477–95.
Google Scholar
Sun K, Lei L, Zheng R, Zhang S, Zeng H, Wang S, et al. Trends in incidence rates, mortality rates, and age-period-cohort effects of female breast cancer—China, 2003–2017. China CDC Wkly. 2023;5(15):340–6.
Google Scholar
Lee SK, Kim SW, Yu JH, Lee JE, Kim JY, Woo J, et al. Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?. Breast Cancer Res Treat. 2019;173(1):189–99.
Google Scholar
Heer E, Ruan Y, Mealey N, Quan ML, Brenner DR. The incidence of breast cancer in Canada 1971–2015: trends in screening-eligible and young-onset age groups. Can J Public Health. 2020;111(5):787–93.
Google Scholar
Partridge AH, Hughes ME, Warner ET, Ottesen RA, Wong YN, Edge SB, et al. Subtype-dependent relationship between young age at diagnosis and breast cancer survival. J Clin Oncol. 2016;34(27):3308–14.
Google Scholar
Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, et al. The IARC perspective on cervical cancer screening. N Engl J Med. 2021;385(20):1908–18.
Google Scholar
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. https://www.who.int/publications/i/item/9789240014107. Accessed 23 October, 2024.
Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Center. 2024;4(1):47–53.
Flor LS, Anderson JA, Ahmad N, Aravkin A, Carr S, Dai X, et al. Health effects associated with exposure to secondhand smoke: a burden of proof study. Nat Med. 2024;30(1):149–67.
Google Scholar
Balmes JR. Household air pollution from domestic combustion of solid fuels and health. J Allergy Clin Immunol. 2019;143(6):1979–87.
Google Scholar
Berg CD, Schiller JH, Boffetta P, Cai J, Connolly C, Kerpel-Fronius A, et al. Air pollution and lung cancer: a review by international association for the study of lung cancer early detection and screening committee. J Thorac Oncol. 2023;18(10):1277–89.
Google Scholar
Adams SJ, Stone E, Baldwin DR, Vliegenthart R, Lee P, Fintelmann FJ. Lung cancer screening. Lancet. 2023;401(10374):390–408.
Google Scholar
Toumazis I, Bastani M, Han SS, Plevritis SK. Risk-based lung cancer screening: a systematic review. Lung Cancer. 2020;147:154–86.
Google Scholar
Yang D, Liu Y, Bai C, Wang X, Powell CA. Epidemiology of lung cancer and lung cancer screening programs in China and the United States. Cancer Lett. 2020;468:82–7.
Google Scholar
Yang JD, Mohamed EA, Aziz AO, Shousha HI, Hashem MB, Nabeel MM, et al. Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium. Lancet Gastroenterol Hepatol. 2017;2(2):103–11.
Google Scholar
McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(Suppl 1):4–13.
Google Scholar
Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, Hutin YJ, et al. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol & Hepatol. 2022;7(8):724–35.
Google Scholar
Bencina G, Oliver E, Meiwald A, Hughes R, Morais E, Weston G, et al. Global burden and economic impact of vaccine-preventable cancer mortality. J Med Econ. 2024;27(sup2):9–19.
Google Scholar
Okeke E, Davwar PM, Roberts L, Sartorius K, Spearman W, Malu A, et al. Epidemiology of liver cancer in Africa: current and future trends. Semin Liver Dis. 2020;40(2):111–23.
Google Scholar
AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord. Comparison of Kaposi sarcoma risk in human immunodeficiency virus-positive adults across 5 continents: a multiregional multicohort study. Clin Infect Dis. 2017;65(8):1316-26.
Fu L, Tian T, Wang B, Lu Z, Gao Y, Sun Y, et al. Global patterns and trends in Kaposi sarcoma incidence: a population-based study. Lancet Glob Health. 2023;11(10):e1566–75.
Google Scholar
Silverstein A, Kamiyango W, Villiera J, Peckham-Gregory EC, McAtee CL, Scheurer ME, et al. Long-term outcomes for children and adolescents with Kaposi sarcoma. HIV Med. 2022;23(2):197–203.
Google Scholar
Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D. Kaposi sarcoma. Nat Rev Dis Primers. 2019;5(1):9.
Google Scholar
Filho AM, Laversanne M, Ferlay J, Colombet M, Piñeros M, Znaor A, et al. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156(7):1336–46.
Google Scholar